Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Star Scientific, Inc.

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Star Scientific,

PR Newswire

NEW YORK, Jan. 24, 2013

NEW YORK, Jan. 24, 2013 /PRNewswire/ --Attorney Advertising--Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims on behalf of
purchasers of the securities of Star Scientific, Inc. ("Star Scientific" or
the "Company")(NasdaqGM: STSI). The investigation focuses on whether the
Company and its executives violated federal securities.

On January 23, 2013, shares of Star Scientific fell 31 cents or 11.74% to
close at $2.33 after the alleged that the Company misled investors
about the involvement of Johns Hopkins University in the clinical testing of
the company's retail nutritional supplement anatabine. According to a Johns
Hopkins School of medicine spokesperson, the school has no official
involvement with Star Scientific or anatabine."The Antabloc Supplementation
Autoimmune Prevention [ASAP] clinical study was not conducted at or approved
by Johns Hopkins," Johns Hopkins' Stephanie Desmon said via email.

If you are aware of any facts relating to this investigation, or purchased
shares of Star Scientific, you can assist this investigation by contacting
either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman,
LLC at 212-697-6484 or via email Those who inquire by e-mail
are encouraged to include their mailing address and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our
primary expertise is the aggressive pursuit of litigation claims on behalf of
our clients.In addition to representing institutions and other investor
plaintiffs in class action security litigation, the firm's expertise includes
general corporate and commercial litigation, as well as securities

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman, 212-697-6484

SOURCE Bronstein, Gewirtz & Grossman, LLC
Press spacebar to pause and continue. Press esc to stop.